isturisa 10 mg
medison pharma ltd - osilodrostat as phosphate - film coated tablets - osilodrostat as phosphate 10 mg - osilodrostat - isturisa is indicated for the treatment of endogenous cushing’s syndrome in adult patients for whom surgery is not an option or has not been curative
isturisa 5 mg
medison pharma ltd - osilodrostat as phosphate - film coated tablets - osilodrostat as phosphate 5 mg - osilodrostat - isturisa is indicated for the treatment of endogenous cushing’s syndrome in adult patients for whom surgery is not an option or has not been curative.
dogmatil 200mg tablets
sanofi-aventis (malaysia) sdn. bhd. - sulpiride -
ketoconazole hra 200 mg
cts ltd - ketoconazole - tablets - ketoconazole 200 mg - ketoconazole - treatment of endogenous cushing's syndrome in adults and adolescents above the age of 12 years.
ketoconazole hra 200 mg
cts ltd - ketoconazole - tablets - ketoconazole 200 mg - ketoconazole - treatment of endogenous cushing's syndrome in adults and adolescents above the age of 12 years.
signifor lar 20 mg injection
key oncologics (pty) ltd - injection - see ingredients - each vial contains pasireotide pamoate equivalent to pasireotide 20,0 mg
signifor lar 40 mg injection
key oncologics (pty) ltd - injection - see ingredients - each vial contains pasireotide pamoate equivalent to pasireotide 40,0 mg
signifor lar 60 mg injection
key oncologics (pty) ltd - injection - see ingredients - each vial contains pasireotide pamoate equivalent to pasireotide 60,0 mg
signifor 0,3 mg /ml injection
novartis south africa (pty) ltd - injection - each ampoule contains pasireotide diaspartate equivalent to pasireotide 0,3 mg
signifor 0,6 mg /ml injection
novartis south africa (pty) ltd - injection - each ampoule contains pasireotide diaspartate equivalent to pasireotide 0,6 mg